Skip to content
Terms & Structures

Warrants and equity kickers in growth lending

Venture debt warrants give lenders potential equity upside. Learn how warrant coverage, exercise prices, share classes, dilution and exit treatment affect the real cost.

Undiluted EditorialPublished 4 min read

In brief

  • A warrant gives the lender a right to buy shares; it is separate from the company’s obligation to repay the loan.
  • Warrant coverage may be expressed as fully diluted ownership or as a percentage of the loan, and the methods are not interchangeable.
  • The real cost depends on the share number, exercise price, class, duration, adjustments and exit treatment—not one percentage.
  • Model warrant dilution and value across downside, expected and upside cases alongside the facility’s cash cost.

A warrant gives a lender the right, but not the obligation, to buy shares under agreed terms. In venture debt it provides potential equity upside alongside interest and fees. It is not free capital: exercise can dilute existing shareholders.

Warrants are common in venture debt, but not universal, and equity participation can also appear in growth credit. The economic effect depends on the full drafting, not the label or one coverage percentage.

The core warrant terms

Read these terms together.
TermWhat it controlsWhy it matters
Number of sharesHow many shares the lender can acquire.The starting point for potential dilution.
Exercise priceThe price paid for each share on exercise.Determines when the warrant has economic value.
Share classThe type of shares issued.Different classes can have different rights and value.
Exercise periodHow long the right lasts.A long life can preserve lender upside through several rounds.
Adjustment provisionsHow the warrant changes after share splits, reorganisations or some financings.Can protect value but also change dilution.
Exit treatmentWhat happens on a sale, merger or listing.Determines whether it is exercised, sold, assumed or cancelled.

A warrant is different from a loan conversion right. The debt normally remains repayable; the lender separately holds the right to buy shares. Exercise usually requires payment of the exercise price unless a cashless mechanism applies.

Two ways to express warrant coverage

Market documents can describe coverage in different ways. Borrowers should translate every method into a number of shares and fully diluted ownership under the same cap table.

Method 1: fully diluted ownership

The term may state that the warrant represents a percentage of the company on a fully diluted basis. Fully diluted means assuming specified options, warrants and convertible securities are included in the share count.

Illustration: if the agreed coverage is 0.5% and the agreed fully diluted share count is 10 million before the warrant, a simplified calculation gives 50,000 warrant shares. The legal formula must address whether the warrant itself is included in the denominator.

Method 2: value relative to the loan

Coverage may instead be stated as a percentage of the loan or commitment. That percentage produces a warrant value, which is divided by the agreed exercise price to calculate shares.

Illustration: 5% coverage on £2 million gives £100,000 of aggregate exercise value. At a £2 exercise price, that produces 50,000 warrant shares. Check whether coverage uses the commitment, amount drawn, peak balance or another figure.

The two examples happen to produce the same shares but are not equivalent methods. A later change in the cap table, loan draw or exercise price can affect them differently.

Exercise price

The exercise price is what the lender pays per share. It may reference the latest equity-round price, a future financing, nominal value or another negotiated measure.

A low exercise price increases potential value. A high exercise price may leave the warrant out of the money, meaning the shares are worth no more than the amount required to buy them.

Check how the price changes after share splits, consolidations, bonus issues or other capital reorganisations. Tax and accounting treatment can depend on the facts and jurisdiction, so specialist advice may be needed.

Share class and rights

The warrant may cover ordinary shares, the latest preferred class or the securities issued in a future round. Those shares can carry different voting, dividend, conversion and sale rights.

If the warrant converts into another class on an exit or financing, model that path. Counting shares alone can understate or overstate economic value.

When the warrant is earned

Coverage may be granted on signing, closing, each drawing or only when a tranche becomes available. A lender may request coverage on the whole commitment even when later tranches are conditional.

Match the equity participation to capital genuinely committed or drawn. If a tranche expires unused, establish whether the related warrant remains outstanding.

Duration and exercise

The exercise period may outlast the loan. Repaying or refinancing the debt does not automatically cancel the warrant unless the documents say so.

Exercise can be voluntary, automatic on specified events or cashless. In a cashless exercise, the holder receives fewer shares representing the warrant’s net value rather than paying the full exercise price in cash.

Exit treatment

On a company sale, the warrant may be exercised immediately before completion, converted through a cashless formula, assumed by the buyer or settled in cash. Confirm the mechanics early because they can affect transaction proceeds and closing steps.

An initial public offering or reorganisation may trigger different treatment. Review notice periods and information rights so the warrant does not delay an exit.

Dilution in context

Dilution means an existing shareholder owns a smaller percentage after new shares are issued. The warrant’s percentage can change as the company issues more shares, unless adjustment rights protect it.

Compare the warrant with the equity the company avoids raising by using debt, but do not call venture debt non-dilutive. Debt may reduce immediate dilution relative to an equity round while still creating warrant dilution and a repayment obligation.

Model at least three outcomes: a lower-value exit, the expected equity case and a strong upside case. Include future financing dilution, the share class, exercise price and any adjustments.

Worked ownership illustration

Assume 10 million fully diluted shares before a 50,000-share warrant. On a simple post-issue basis, the warrant represents about 0.50% because 50,000 is divided by 10.05 million. If a later round adds two million shares without an adjustment, it falls to about 0.41%.

The lender’s cash gain also depends on value per share. If exit value per warrant share is £8 and the exercise price is £2, the gross spread is £6 per share, or £300,000 across 50,000 shares, before tax and transaction mechanics. These numbers are illustrative, not market terms.

Negotiation questions

  1. Is coverage based on commitment, availability or actual drawings?
  2. Which fully diluted share count and share class are used?
  3. How is the exercise price set and adjusted?
  4. When is the warrant issued or earned?
  5. Does repayment affect the warrant?
  6. What happens on a sale, listing, financing or reorganisation?
  7. Can exercise be cashless and who bears administrative costs?
  8. Are information, transfer or registration rights attached?

The bottom line

A venture debt warrant is a separate equity instrument whose cost depends on shares, price, class, timing and exit treatment. Coverage language is only the start.

Translate the term sheet into shares and ownership, then model several company outcomes. Compare that equity cost alongside the loan’s cash cost, controls and repayment risk.

Where to go next

Share

Continue learning

Next in Terms & Structures

Covenants in growth lending

Understand growth debt and venture debt covenants, including reporting duties, restricted actions, minimum liquidity, performance tests, headroom and cures.

Continue

Previous: Growth debt interest rates and costs

NewsletterThe Stack

Fortnightly global venture debt & growth credit news — straight to your inbox.

By subscribing, you agree to our Privacy Policy.